Is it possible to change phenotype progression in crohn's disease in the era of immunomodulators? predictive factors of phenotype progression

American Journal of Gastroenterology

Volumn 109, Issue 7, 2014, Pages 1026-1036

  Magro, Fernando ^a,b,c   Rodrigues Pinto, Eduardo ^a   Coelho, Rosa ^a   Andrade, Patrícia ^a   Santos Antunes, João ^a,b   Lopes, Susana ^a   Camila Dias, Claudia ^b   MacEdo, Guilherme ^a  

^a Universidade do Porto   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; STEROID;

ADULT; ARTICLE; CROHN DISEASE; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRIORITY JOURNAL; THERAPY DELAY; TREATMENT DURATION; UPPER GASTROINTESTINAL TRACT;

ADULT; AZATHIOPRINE; CROHN DISEASE; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903900714     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.97     Document Type: Article

References (29)

1. Tarrant KM, Barclay ML, Frampton CM et al. Perianal disease predicts changes in Crohn's disease phenotype results of a population-based study of infammatory bowel disease phenotype. Am J Gastroenterol 2008;103:3082-93.
2. Barrett JC, Hansoul S, Nicolae DL et al. Genomewide association def nes more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
3. Peyrin-Biroulet L, Standaert-Vitse A, Branche J et al. IBD serological panels: facts and perspectives. Infamm Bowel Dis 2007;13:1561-6.
4. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ et al. Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 2008;372:67-81.
5. Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
6. Sachar DB, Adrews HA, Farmer RG et al. Proposed classification of patient subgroups in Crohn's disease. Gastroenterol Int 1992;5:141-54.
7. Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease: report of the working party of the world congresses of gastroenter-ology, Vienna 1998. Infamm Bowel Dis 2000;6:8-15.
8. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inf ammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastro-enterology. Can J Gastroenterol 2005;19:Suppl A: 5-36.
9. Louis E, Collard A, Oger AF et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
10. Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behaviour of Crohn's disease. Infamm Bowel Dis 2002;8:244-50.
11. Solberg IC, Vatn MH, Hø ie O et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007;5:1430-8.
12. Burisch J, Pedersen N, Cukovic-Cavka S et al. East-West gradient in the incidence of inf ammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014;63:588-97.
13. Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifers? Gastroenterology 2008;135:1442-7.
14. D'Haens GR, Fedorak R, Lemann M et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Infamm Bowel Dis 2009;15:1599-604.
15. Peyrin-Biroulet L, Bigard MA, Malesci A et al. Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late. Gastroenterology 2008; 135: 1420-2.
16. Bernstein CN, Lofus EV, Ng SC et al. Hospitalisations and surgery in Crohn's disease. Gut 2012;61:622-9.
17. Dignass A, VanAssche G, Lindsay JO et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010; 4: 28-62.
18. Henriksen M, Jahnsen J, Lygren I et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study. Scand J Gastroenterol 2007;42:602-10.
19. Vist GE, Hagen KB, Devereaux PJ et al. Systematic review to determine whether participation in a trial infuences outcome. BMJ 2005;330:1175.
20. Peyrin-Biroulet L, Lofus EV Jr, Colombel JF et al. Early Crohn disease: a proposed def nition for use in disease-modifcation trials. Gut 2010;59: 141-7.
21. Tia KT, Sandborn WJ, Harmsen WS et al. R isk facto rs asso ciated w ith progression to intestinal complications of Crohn's disease in a population-basedcohort. Gastroenterology 2010;139:1147-55.
22. Lakatos PL, Czegledi Z, Szamosi T et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behaviour change in patients with Crohn's disease. World J Gastroenterol 2009;15:3504-10.
23. Romberg-Camps MJ, Dagnelie PC, Kester AD et al. I n f uence of pheno-type at diagnosis and of other potential prognostic factors on the course of infammatory bowel disease. Am J Gastroenterol 2009;104:371-83.
24. Mahid SS, Minor KS, Stevens PL et al. The role of smoking in Crohn's disease as def ned by clinical variables. Dig Dis Sci 2007; 52: 2897-903.
25. Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localization and clinical course. Gut 1992;33:779-82.
26. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with f stulizing and structuring behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003; 98: 363-8.
27. Aldhous MC, Drummond HE, Anderson N et al. Does cigarette smoking inf uence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol 2007; 102: 577-88.
28. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ et al. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol 2012;107:1693-701.
29. Lakatos PL, Golovics PA, David G et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012;107:579-88.